Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
Nov. 30, 2018
Nov. 30, 2017
CURRENT    
Cash and cash equivalents $ 1,182,387 $ 1,965,043
Accounts receivable, net 18,914 36,412
Inventory (Note 15) 129,121 157,303
Prepaid expenses and other receivables (Note 17) 901,247 6,648
Total Current Assets 2,231,669 2,165,406
Patent rights (Note 16) 106,334  
Deposit for equipment (Note 9) 205,664  
Property and equipment, net (Note 9) 113,418 26,951
TOTAL ASSETS 2,657,085 2,192,357
CURRENT LIABILITIES    
Accounts payable and accrued liabilities (Notes 4 and 8) 397,309 393,341
Unsecured convertible debentures (Note 14)   40,357
Secured convertible debentures (Note 14) 978,361  
Derivative liabilities (Note 14) 957,301 539,860
Total Current Liabilities 2,332,971 973,558
Long term secured convertible debentures (Note 14)   892,176
Long term convertible notes (Note 14) 167,077  
Total Liabilities 2,500,048 1,865,734
Commitments (Notes 11, 12 and 14)
Capital stock (Note 5)    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, nil issued and outstanding (2017 - nil).
Common stock, $0.001 par value 200,000,000 shares authorized, 101,976,900 issued and outstanding (2017: 93,014,134) 101,977 93,014
Additional paid-in capital 33,341,695 31,365,097
Accumulated deficit (33,252,338) (31,098,864)
Accumulated other comprehensive loss (34,297) (32,624)
Total Stockholders? Equity 157,037 326,623
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,657,085 $ 2,192,357